Who owns BIOLINE RX LIMITED SPONSORED ADR?
- Ticker: BLRX
- CUSIP Number: 09071m304
Tip: Access positions for across all investors
Analyze quarterly positions in Bioline Rx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioline Rx stock
Who bought or sold BIOLINE RX LIMITED SPONSORED ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 20k | $76k | 82% | Sep 2025 |
|
| Citadel Advisors | 10k | $38k | -86% | Sep 2025 |
|
| UBS Group | 6.4k | $24k | 100% | Sep 2025 |
|
| Rhumbline Advisers | 3.1k | $12k | -28% | Sep 2025 |
|
| Wells Fargo & Company | 1.8k | $6.6k | 0% | Sep 2025 |
|
| Nemes Rush Group | 250.00 | $945.000000 | 0% | Sep 2025 |
|
| Goss Wealth Management | 107.00 | $404.995000 | 0% | Sep 2025 |
|
| Simplex Trading | 105.00 | $0 | -99% | Sep 2025 |
|
| Tower Research Capital | 39.00 | $146.998800 | 100% | Sep 2025 |
|
| Rockefeller Capital Management | 12.00 | $45.000000 | 100% | Sep 2025 |
|
| SBI Securities | 2.00 | $8.000000 | 0% | Sep 2025 |
|
| Danske Bank A/s | 2.00 | $8.000000 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 1.00 | $3.000000 | 0% | Sep 2025 |
|
Who sold out of Bioline Rx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Jun 2025 | 14k | $63k |
| National Bank Of Canada /fi/ | Jun 2025 | 200.00 | $914.000000 |
| Raymond James Financial | Jun 2025 | 72.00 | $328.982400 |
| Fifth Third Bancorp | Jun 2025 | 25.00 | $114.000000 |